Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Evaluation of the cutaneous sensation of the face in patients with different clinical forms of leprosy.

Oliveira MF, Antunes DE, Santos DFD, Goulart IMB.

PLoS One. 2019 Mar 14;14(3):e0213842. doi: 10.1371/journal.pone.0213842. eCollection 2019.

2.

Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.

Nahas AA, Lima MIS, Goulart IMB, Goulart LR.

Front Immunol. 2018 May 30;9:1205. doi: 10.3389/fimmu.2018.01205. eCollection 2018.

3.

Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts.

Santos DFD, Mendonça MR, Antunes DE, Sabino EFP, Pereira RC, Goulart LR, Goulart IMB.

PLoS Negl Trop Dis. 2018 May 21;12(5):e0006494. doi: 10.1371/journal.pntd.0006494. eCollection 2018 May.

4.

Are leprosy case numbers reliable?

Salgado CG, Barreto JG, da Silva MB, Goulart IMB, Barreto JA, de Medeiros Junior NF, Nery JA, Frade MAC, Spencer JS.

Lancet Infect Dis. 2018 Feb;18(2):135-137. doi: 10.1016/S1473-3099(18)30012-4. No abstract available.

PMID:
29412953
5.

A novel vitamin D receptor polymorphism associated with leprosy.

Araújo TG, Oliveira GP, de Matos Oliveira F, Neves AF, Soares Mota ST, Goulart IMB, Goulart LR.

J Dermatol Sci. 2018 Mar;89(3):304-307. doi: 10.1016/j.jdermsci.2017.12.007. Epub 2017 Dec 23. No abstract available.

PMID:
29290530
6.

Revisiting primary neural leprosy: Clinical, serological, molecular, and neurophysiological aspects.

Santos DFD, Mendonça MR, Antunes DE, Sabino EFP, Pereira RC, Goulart LR, Goulart IMB.

PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0006086. doi: 10.1371/journal.pntd.0006086. eCollection 2017 Nov.

7.

qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.

Araujo S, Goulart LR, Truman RW, Goulart IMB, Vissa V, Li W, Matsuoka M, Suffys P, Fontes AB, Rosa PS, Scollard DM, Williams DL.

PLoS Negl Trop Dis. 2017 Jun 1;11(6):e0005506. doi: 10.1371/journal.pntd.0005506. eCollection 2017 Jun.

8.

Number of leprosy reactions during treatment: clinical correlations and laboratory diagnosis.

Antunes DE, Ferreira GP, Nicchio MV, Araujo S, Cunha AC, Gomes RR, Costa AV, Goulart IM.

Rev Soc Bras Med Trop. 2016 Nov-Dec;49(6):741-745. doi: 10.1590/0037-8682-0440-2015.

9.

Molecular Evidence for the Aerial Route of Infection of Mycobacterium leprae and the Role of Asymptomatic Carriers in the Persistence of Leprosy.

Araujo S, Freitas LO, Goulart LR, Goulart IM.

Clin Infect Dis. 2016 Dec 1;63(11):1412-1420. Epub 2016 Aug 23.

PMID:
27558564
10.

Spatial and temporal epidemiology of Mycobacterium leprae infection among leprosy patients and household contacts of an endemic region in Southeast Brazil.

Nicchio MV, Araujo S, Martins LC, Pinheiro AV, Pereira DC, Borges A, Antunes DE, Barreto JG, Goulart IM.

Acta Trop. 2016 Nov;163:38-45. doi: 10.1016/j.actatropica.2016.07.019. Epub 2016 Jul 25.

PMID:
27469619
11.

Trypanosoma cruzi modulates gene expression of plasma membrane repair-related proteins.

Brígido RTES, Tavares PCB, Santos MAD, Santos JG, Souza MA, Goulart IMB, Silva CVD.

Acta Trop. 2017 Oct;174:153-157. doi: 10.1016/j.actatropica.2016.06.008. Epub 2016 Jun 8.

12.

Diagnosis of mycobacterial infections based on acid-fast bacilli test and bacterial growth time and implications on treatment and disease outcome.

Riello FN, Brígido RT, Araújo S, Moreira TA, Goulart LR, Goulart IM.

BMC Infect Dis. 2016 Apr 1;16:142. doi: 10.1186/s12879-016-1474-6.

13.

Risk-benefit assessment of Bacillus Calmette-Guérin vaccination, anti-phenolic glycolipid I serology, and Mitsuda test response: 10-year follow-up of household contacts of leprosy patients.

Araujo S, Rezende MM, Sousa DC, Rosa MR, Santos DC, Goulart LR, Goulart IM.

Rev Soc Bras Med Trop. 2015 Nov-Dec;48(6):739-45. doi: 10.1590/0037-8682-0245-2015.

14.

Application of the SRQ20 and the protocol of psychological assessment in patients with leprosy in a Reference Centre in Brazil.

Cunha MA, Antunes DE, Da Silveira RW, Goulart IM.

Lepr Rev. 2015 Sep;86(3):229-39.

PMID:
26665358
15.

Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal.

Khadge S, Banu S, Bobosha K, van der Ploeg-van Schip JJ, Goulart IM, Thapa P, Kunwar CB, van Meijgaarden KE, van den Eeden SJ, Wilson L, Kabir S, Dey H, Goulart LR, Lobato J, Carvalho W, Bekele Y, Franken KL, Aseffa A, Spencer JS, Oskam L, Otttenhoff TH, Hagge DA, Geluk A.

BMC Infect Dis. 2015 Oct 28;15:477. doi: 10.1186/s12879-015-1128-0.

16.

Asymptomatic Leprosy Infection among Blood Donors May Predict Disease Development and Suggests a Potential Mode of Transmission.

Goulart IM, Araujo S, Filho AB, de Paiva PH, Goulart LR.

J Clin Microbiol. 2015 Oct;53(10):3345-8. doi: 10.1128/JCM.01305-15. Epub 2015 Jul 22.

17.

Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.

da Conceição Oliveira Coelho Fabri A, Carvalho AP, Araujo S, Goulart LR, de Mattos AM, Teixeira HC, Goulart IM, Duthie MS, Correa-Oliveira R, Lana FC.

BMC Infect Dis. 2015 May 30;15:218. doi: 10.1186/s12879-015-0962-4.

18.

Neural complications and physical disabilities in leprosy in a capital of northeastern Brazil with high endemicity.

Araujo e Araújo AE, Aquino DM, Goulart IM, Pereira SR, Figueiredo IA, Serra HO, Fonseca PC, Caldas Ade J.

Rev Bras Epidemiol. 2014 Dec;17(4):899-910. English, Portuguese.

19.

Factors associated with neural alterations and physical disabilities in patients with leprosy in São Luis, State of Maranhão, Brazil.

Araujo AE, Aquino DM, Goulart IM, Pereira SR, Figueiredo IA, Serra HO, de Almeida Fonseca PC, de Jesus Mendes Caldas A.

Rev Soc Bras Med Trop. 2014 Jul;47(4):490-7.

20.

Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy.

Antunes DE, Araujo S, Ferreira GP, Cunha AC, Costa AV, Gonçalves MA, Goulart IM.

Mem Inst Oswaldo Cruz. 2013 Nov;108(7):901-8. doi: 10.1590/0074-0276130222.

21.

Mycobacterium leprae DNA in peripheral blood may indicate a bacilli migration route and high-risk for leprosy onset.

Reis EM, Araujo S, Lobato J, Neves AF, Costa AV, Gonçalves MA, Goulart LR, Goulart IM.

Clin Microbiol Infect. 2014 May;20(5):447-52. doi: 10.1111/1469-0691.12349. Epub 2013 Aug 28.

22.

Bacterial load in the nose and its correlation to the immune response in leprosy patients.

Naves Mde M, Ribeiro FA, Patrocinio LG, Patrocinio JA, Fleury RN, Goulart IM.

Lepr Rev. 2013 Mar;84(1):85-91.

PMID:
23741885
23.

Unveiling healthy carriers and subclinical infections among household contacts of leprosy patients who play potential roles in the disease chain of transmission.

Araújo S, Lobato J, Reis Ede M, Souza DO, Gonçalves MA, Costa AV, Goulart LR, Goulart IM.

Mem Inst Oswaldo Cruz. 2012 Dec;107 Suppl 1:55-9.

24.

Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection.

Lobato J, Costa MP, Reis Ede M, Gonçalves MA, Spencer JS, Brennan PJ, Goulart LR, Goulart IM.

Lepr Rev. 2011 Dec;82(4):389-401.

PMID:
22439279
25.

Oral lesion in leprosy: borderline tuberculoid diagnosis based on detection of Mycobacterium leprae DNA by qPCR.

da Silva Martinez T, Nahas AA, Figueira MM, Costa AV, Gonçalves MA, Goulart LR, Goulart IM.

Acta Derm Venereol. 2011 Oct;91(6):704-7. doi: 10.2340/00015555-1175.

26.

Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers.

Duthie MS, Hay MN, Rada EM, Convit J, Ito L, Oyafuso LK, Manini MI, Goulart IM, Lobato J, Goulart LR, Carter D, Reed SG.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1257-65. doi: 10.1007/s10096-011-1221-2. Epub 2011 May 5.

PMID:
21544695
27.

Oral mucosa as a source of Mycobacterium leprae infection and transmission, and implications of bacterial DNA detection and the immunological status.

Martinez TS, Figueira MM, Costa AV, Gonçalves MA, Goulart LR, Goulart IM.

Clin Microbiol Infect. 2011 Nov;17(11):1653-8. doi: 10.1111/j.1469-0691.2010.03453.x. Epub 2011 Mar 3.

28.

Biomarkers for serum diagnosis of infectious diseases and their potential application in novel sensor platforms.

Goulart LR, Vieira CU, Freschi AP, Capparelli FE, Fujimura PT, Almeida JF, Ferreira LF, Goulart IM, Brito-Madurro AG, Madurro JM.

Crit Rev Immunol. 2010;30(2):201-22. Review.

PMID:
20370630
29.

Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases.

Goulart LR, Goulart IM.

Arch Dermatol Res. 2009 Feb;301(2):123-37. doi: 10.1007/s00403-008-0917-3. Epub 2008 Nov 29. Review.

PMID:
19043725
30.

Leprosy: diagnostic and control challenges for a worldwide disease.

Goulart IM, Goulart LR.

Arch Dermatol Res. 2008 Jul;300(6):269-90. doi: 10.1007/s00403-008-0857-y. Epub 2008 May 7. Review.

PMID:
18461340
31.

Evaluation of the agreement between clinical and laboratorial exams in the diagnosis of leprosy.

Teixeira AC, Cruvinel DL, Roma FR, Luppino LF, Resende LH, Sousa Td, Bührer-Sékula S, Goulart IM.

Rev Soc Bras Med Trop. 2008;41 Suppl 2:48-55.

32.

Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts.

Goulart IM, Bernardes Souza DO, Marques CR, Pimenta VL, Gonçalves MA, Goulart LR.

Clin Vaccine Immunol. 2008 Jan;15(1):101-5. Epub 2007 Nov 7.

33.

Detection of Mycobacterium leprae DNA in skin lesions of leprosy patients by PCR may be affected by amplicon size.

Goulart IM, Cardoso AM, Santos MS, Gonçalves MA, Pereira JE, Goulart LR.

Arch Dermatol Res. 2007 Aug;299(5-6):267-71. Epub 2007 May 26.

PMID:
17530267
34.
35.

Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.

Goulart IM, Reis AC, De Rezende TM, Borges AS, Ferreira MS, Nishioka SA.

Lepr Rev. 2005 Jun;76(2):167-9. No abstract available.

PMID:
16038251
36.

Detection of Mycobacterium leprae in nasal mucosa biopsies by the polymerase chain reaction.

Patrocínio LG, Goulart IM, Goulart LR, Patrocínio JA, Ferreira FR, Fleury RN.

FEMS Immunol Med Microbiol. 2005 Jun 1;44(3):311-6.

37.

Susceptibility to leprosy may be conditioned by an interaction between the NRAMP1 promoter polymorphisms and the lepromin response.

Ferreira FR, Goulart LR, Silva HD, Goulart IM.

Int J Lepr Other Mycobact Dis. 2004 Dec;72(4):457-67.

PMID:
15755200
38.

Is MUC1 polymorphism associated with female infertility?

Goulart LR, Vieira GS, Martelli L, Inácio J, Goulart IM, Franco JG Jr.

Reprod Biomed Online. 2004 Apr;8(4):477-82.

PMID:
15149576
39.

Amyotrophic lateral sclerosis in a patient with leprosy peripheral neuropathy.

Goulart IM, Nishioka Sde A, Ruiz Júnior FB, Borges AS, Mendonça CN.

Int J Lepr Other Mycobact Dis. 2003 Sep;71(3):244-5. No abstract available.

PMID:
14608821
40.

[Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center of the Federal University of Uberlândia].

Goulart IM, Arbex GL, Carneiro MH, Rodrigues MS, Gadia R.

Rev Soc Bras Med Trop. 2002 Sep-Oct;35(5):453-60. Epub 2002 Nov 29. Portuguese.

41.

Concurrent leprosy and leishmaniasis with mucosal involvement.

Goulart IM, Patrocínio LG, Nishioka Sde A, Patrocínio JA, Ferreira MS, Fleury RN.

Lepr Rev. 2002 Sep;73(3):283-4. No abstract available.

PMID:
12449897
42.

[Immunopathology of leprosy: the complexity of the mechanisms of host immune response to Mycobacterium leprae].

Goulart IM, Penna GO, Cunha G.

Rev Soc Bras Med Trop. 2002 Jul-Aug;35(4):365-75. Review. Portuguese.

44.

Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy.

Goulart IM, Figueiredo F, Coimbra T, Foss NT.

Am J Pathol. 1996 Mar;148(3):911-7.

45.

Necrotizing erythema nodosum leprosum triggered by cotrimoxazole?

Nishioka Sde A, Goulart IM, Burgarelli MK, Ferreira MS, Nunes-Araújo FR.

Int J Lepr Other Mycobact Dis. 1994 Jun;62(2):296-7. No abstract available.

PMID:
8046270
46.

Assessment of BCG protective efficacy by case-control studies.

Nishioka Sde A, Goulart IM.

Int J Lepr Other Mycobact Dis. 1993 Sep;61(3):459-62. No abstract available.

PMID:
8228446
47.

Severe thrombocytopenia and intermittent use of rifampin.

Nishioka SA, Goulart IM, Nunes-Araújo FR, Arantes SC, Burgarelli MK, Ferreira MS, dos Santos RP, Lopes VR.

Int J Lepr Other Mycobact Dis. 1992 Jun;60(2):273-4. No abstract available.

PMID:
1522369

Supplemental Content

Loading ...
Support Center